Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Esophagogastroduodenoscopy | Research

Relationship between observation time and detection rate of focal lesions in Esophagogastroduodenoscopy: a single-center, retrospective study

Authors: Li Dong, Xiaodan Zhang, Yuting Xuan, Peiling Xiong, Yumei Ning, Bing Zhang, Fan Wang, Qiu Zhao, Jun Fang

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Background

Current studies have shown that longer observation time can improve neoplastic detection rate. This study aimed to clarify whether endoscopists with longer observation times can detect more focal lesions.

Methods

Based on the mean examination time for Esophagogastroduodenoscopy (EGD) without biopsy, endoscopists were divided into fast and slow groups, and the detection rate of focal lesions was compared between the two groups. Univariate analysis, multivariate analysis and restricted cubic spline were used to explore the factors of focal lesion detection rate.

Results

Mean examination time of EGD without biopsy was 4.5 min. The cut-off times used were 5 min. 17 endoscopists were classified into the fast (4.7 ± 3.6 min), and 16 into the slow (7.11 ± 4.6 min) groups. Compared with fast endoscopists, slow endoscopists had a higher detection rate of focal lesions (47.2% vs. 51.4%, P < 0.001), especially in the detection of gastric lesions (29.7% vs. 35.9%, P < 0.001). In univariate and multivariate analyses, observation time, patient age and gender, expert, biopsy rate, and number of images were factors in FDR. There is a nonlinear relationship between observation time and FDR.

Conclusion

Longer examination time improves the detection rate of focal lesions. Observation time is an important quality indicator of the EGD examination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
2.
go back to reference Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158(3):693–702.CrossRefPubMed Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158(3):693–702.CrossRefPubMed
3.
go back to reference Teh JL, Tan JR, Lau LJ, Saxena N, Salim A, Tay A, Shabbir A, Chung S, Hartman M, So JB. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol. 2015;13(3):480–487e482.CrossRefPubMed Teh JL, Tan JR, Lau LJ, Saxena N, Salim A, Tay A, Shabbir A, Chung S, Hartman M, So JB. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol. 2015;13(3):480–487e482.CrossRefPubMed
4.
go back to reference Wang YR, Loftus EV Jr., Judge TA, Peikin SR. Rate and predictors of interval esophageal and gastric cancers after Esophagogastroduodenoscopy in the United States. Digestion. 2016;94(3):176–80.CrossRefPubMed Wang YR, Loftus EV Jr., Judge TA, Peikin SR. Rate and predictors of interval esophageal and gastric cancers after Esophagogastroduodenoscopy in the United States. Digestion. 2016;94(3):176–80.CrossRefPubMed
5.
go back to reference Chadwick G, Groene O, Riley S, Hardwick R, Crosby T, Hoare J, Hanna GB, Greenaway K, Cromwell DA. Gastric cancers missed during Endoscopy in England. Clin Gastroenterol H. 2015;13(7):1264–.CrossRef Chadwick G, Groene O, Riley S, Hardwick R, Crosby T, Hoare J, Hanna GB, Greenaway K, Cromwell DA. Gastric cancers missed during Endoscopy in England. Clin Gastroenterol H. 2015;13(7):1264–.CrossRef
6.
go back to reference Hosokawa O, Tsuda S, Kidani E, Watanabe K, Tanigawa Y, Shirasaki S, Hayashi H, Hinoshita T. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy. 1998;30(8):669–74.CrossRefPubMed Hosokawa O, Tsuda S, Kidani E, Watanabe K, Tanigawa Y, Shirasaki S, Hayashi H, Hinoshita T. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy. 1998;30(8):669–74.CrossRefPubMed
7.
go back to reference Yalamarthi S, Witherspoon P, McCole D, Auld CD. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy. 2004;36(10):874–9.CrossRefPubMed Yalamarthi S, Witherspoon P, McCole D, Auld CD. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy. 2004;36(10):874–9.CrossRefPubMed
8.
go back to reference Pimenta-Melo AR, Monteiro-Soares M, Libanio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041–9.CrossRefPubMed Pimenta-Melo AR, Monteiro-Soares M, Libanio D, Dinis-Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041–9.CrossRefPubMed
10.
go back to reference Kawamura T, Wada H, Sakiyama N, Ueda Y, Shirakawa A, Okada Y, Sanada K, Nakase K, Mandai K, Suzuki A, et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29(5):569–75.CrossRefPubMed Kawamura T, Wada H, Sakiyama N, Ueda Y, Shirakawa A, Okada Y, Sanada K, Nakase K, Mandai K, Suzuki A, et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29(5):569–75.CrossRefPubMed
11.
go back to reference Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer Observation Time increases proportion of Neoplasms detected by Esophagogastroduodenoscopy. Gastroenterology. 2017;153(2):460–469e461.CrossRefPubMed Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer Observation Time increases proportion of Neoplasms detected by Esophagogastroduodenoscopy. Gastroenterology. 2017;153(2):460–469e461.CrossRefPubMed
12.
go back to reference Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76(3):531–8.CrossRefPubMed Gupta N, Gaddam S, Wani SB, Bansal A, Rastogi A, Sharma P. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012;76(3):531–8.CrossRefPubMed
13.
go back to reference Unno S, Igarashi K, Saito H, Hirasawa D, Okuzono T, Tanaka Y, Nakahori M, Matsuda T. Assigning a different endoscopist for each annual follow-up may contribute to improved gastric cancer detection rates. Endosc Int Open. 2022;10(10):E1333–42.CrossRefPubMedPubMedCentral Unno S, Igarashi K, Saito H, Hirasawa D, Okuzono T, Tanaka Y, Nakahori M, Matsuda T. Assigning a different endoscopist for each annual follow-up may contribute to improved gastric cancer detection rates. Endosc Int Open. 2022;10(10):E1333–42.CrossRefPubMedPubMedCentral
14.
go back to reference Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa De Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–88.CrossRefPubMed Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa De Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–88.CrossRefPubMed
15.
go back to reference Chiu PWY, Uedo N, Singh R, Gotoda T, Ng EKW, Yao K, Ang TL, Ho SH, Kikuchi D, Yao F, et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut. 2019;68(2):186–97.CrossRefPubMed Chiu PWY, Uedo N, Singh R, Gotoda T, Ng EKW, Yao K, Ang TL, Ho SH, Kikuchi D, Yao F, et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut. 2019;68(2):186–97.CrossRefPubMed
16.
go back to reference Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, Pech O, Ragunath K, Weusten B, Familiari P, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48(9):843–64.CrossRefPubMed Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, Pech O, Ragunath K, Weusten B, Familiari P, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48(9):843–64.CrossRefPubMed
17.
go back to reference Lee SH, Park YK, Cho SM, Kang JK, Lee DJ. Technical skills and training of upper gastrointestinal endoscopy for new beginners. World J Gastroenterol. 2015;21(3):759–85.CrossRefPubMedPubMedCentral Lee SH, Park YK, Cho SM, Kang JK, Lee DJ. Technical skills and training of upper gastrointestinal endoscopy for new beginners. World J Gastroenterol. 2015;21(3):759–85.CrossRefPubMedPubMedCentral
18.
go back to reference Secknus R. [Endoscopy of the upper gastrointestinal tract]. Internist (Berl). 2004;45(12):1407–16. quiz 1417– 1408.CrossRefPubMed Secknus R. [Endoscopy of the upper gastrointestinal tract]. Internist (Berl). 2004;45(12):1407–16. quiz 1417– 1408.CrossRefPubMed
19.
go back to reference Namasivayam V, Uedo N. Quality indicators in the endoscopic detection of gastric cancer. DEN Open 2023, 3(1). Namasivayam V, Uedo N. Quality indicators in the endoscopic detection of gastric cancer. DEN Open 2023, 3(1).
20.
go back to reference Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of Atrophic gastritis: Expert Review. Gastroenterology. 2021;161(4):1325–1332e1327.CrossRefPubMed Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of Atrophic gastritis: Expert Review. Gastroenterology. 2021;161(4):1325–1332e1327.CrossRefPubMed
21.
go back to reference Chen MJ, Wu W, Pan S, Lin CJ, Dong LM, Chen ZF, Wu JS, Huang ZM. Sedated gastroscopy improves detection of gastric polyps. Exp Ther Med. 2018;16(4):3116–20.PubMedPubMedCentral Chen MJ, Wu W, Pan S, Lin CJ, Dong LM, Chen ZF, Wu JS, Huang ZM. Sedated gastroscopy improves detection of gastric polyps. Exp Ther Med. 2018;16(4):3116–20.PubMedPubMedCentral
22.
go back to reference Liang M, Xu C, Zhang X, Zhang Z, Cao J. Effect of anesthesia assistance on the detection rate of precancerous lesions and early esophageal squamous cell cancer in esophagogastroduodenoscopy screening: a retrospective study based on propensity score matching. Front Med (Lausanne). 2023;10:1039979.CrossRefPubMed Liang M, Xu C, Zhang X, Zhang Z, Cao J. Effect of anesthesia assistance on the detection rate of precancerous lesions and early esophageal squamous cell cancer in esophagogastroduodenoscopy screening: a retrospective study based on propensity score matching. Front Med (Lausanne). 2023;10:1039979.CrossRefPubMed
23.
go back to reference Zhou J, Li Z, Ji R, Wang P, Zhang A, Wu K, Liu C, Niu Q, Chu Y, Su X, et al. Influence of Sedation on the detection rate of Early Cancer and Precancerous lesions during Diagnostic Upper gastrointestinal endoscopies: a Multicenter Retrospective Study. Am J Gastroenterol. 2021;116(6):1230–7.CrossRefPubMed Zhou J, Li Z, Ji R, Wang P, Zhang A, Wu K, Liu C, Niu Q, Chu Y, Su X, et al. Influence of Sedation on the detection rate of Early Cancer and Precancerous lesions during Diagnostic Upper gastrointestinal endoscopies: a Multicenter Retrospective Study. Am J Gastroenterol. 2021;116(6):1230–7.CrossRefPubMed
Metadata
Title
Relationship between observation time and detection rate of focal lesions in Esophagogastroduodenoscopy: a single-center, retrospective study
Authors
Li Dong
Xiaodan Zhang
Yuting Xuan
Peiling Xiong
Yumei Ning
Bing Zhang
Fan Wang
Qiu Zhao
Jun Fang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03157-3

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.